Skip Navigation

Help us improve malaria diagnosis and treatment

The ACT Consortium will announce a global campaign to help improve malaria diagnosis and treatment, during the first international summit on Social and Behaviour Change Communication, in Ethiopia, on 8-10 February.

Malaria research publications

Browse through more than 80 journal articles published by ACT Consortium investigators on the access, targeting, safety and quality of antimalarials.

Why every dollar counts for global health

Every dollar in the 2016 replenishment will count for the Global Fund's effort in accomplishing the Sustainable Development Goals (SDGs).

Videos and more

Visit our multimedia section to watch videos and animations, browse a prezi and listen to podcasts with ACT Consortium investigators talking about their studies on the access, targeting, quality and safety of ACT drugs.

View all ACT Consortium news

The ACT Consortium is an international research collaboration formed in November 2007 to answer key questions on malaria drug delivery in Africa and Asia.  

Our goal is to develop and evaluate delivery mechanisms to improve ACT access, targeting, safety and quality. 

The ACT Consortium is funded by the Bill & Melinda Gates Foundation and has partners throughout Africa, Asia, Europe and the United States.  It is coordinated through the London School of Hygiene & Tropical Medicine.